CLINICAL_TRIALS
ClinicalTrials.gov record update
Evaluation of 18F-Fluciclovine PET-MRI as a Biomarker of Response in Pediatric and Young Adult Patients With Low Grade Gliomas (LGG)
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT05555550
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:28:53.326657+00:00
- Published At
- 2025-12-04T00:00:00+00:00
- Record Updated At
- 2025-12-04
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Glioma", "Low-grade Glioma", "Low Grade Glioma of Brain", "Glioma, Malignant", "Glioma Intracranial"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-12-04"- protocolSection.identificationModule.nctId
"NCT05555550"- protocolSection.identificationModule.officialTitle
"Evaluation of 18F-Fluciclovine PET-MRI as a Biomarker of Response in Pediatric and Young Adult Patients With Low Grade Gliomas (LGG)"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
["EARLY_PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.